| Page 1827 | Kisaco Research
 
CAR-T Congress EU 2020
28-30 Jan 2020
London, United Kingdom
Be part of the movement as CAR-T Therapy shapes the future of oncology.The promise of the revolutionary oncology treatment, CAR-T therapy, has become a reality this year, with end-stage cancer patients treated on public health services across the world. As CAR-T moves into the public domain, battle has commenced in the race to effectively commercialise this ground-breaking therapy.The CAR-T Congress is bringing together leading biotechs, late-stage researchers and global pharmaceutical leaders to promote and share research that will break down barriers in R&D through novel data. In our fourth annual congress, we are introducing a new pre-day focused on NK Cell Therapy and the event will run alongside our Vein-to-Vein Congress, so you can tailor your agenda and learn more about cell therapies and their manufacturing. Having listened to the market demands, this year we will be bringing you even more industry-driven understanding of translational applications of the science that drives R&D in CAR-T. Tackle the next hurdles for allogeneic treatments by limiting graft vs host disease through the use of iPSC, and increase the efficacy of these treatments in solid tumours through combination therapies and solid tumour manipulation.Talks run by biotechs, pharma and regulatory bodies, will put you in a position to make informed decisions when commercialising your CAR-T therapy.
Visit Site
 
Phage Futures Europe
23-24 Nov 2021
Brussels, Belgium
Join us for the return of Phage Futures Europe, this November 2021 in Brussels, as we continue all-important discussions on translating new phage-based applications into clinical studies and beyond. Network and learn from multinational pharma, emerging biotechs, leading academics, investment representatives and regulatory bodies to discover how you can be at the forefront of the developing phage therapy market.Introducing face-to-face interactions once again, Phage Futures Europe will help you maximise networking and commercial development with key industry players such as GSK, BiomX, Contrafect and more. This year, we discuss the viability of phage derived lysines in therapy, assess the therapeutic application of natural phages vs engineered phages and explore the clinical data surrounding the magisterial and compassionate use of phages in Europe. Bacteriophages have seen continued investment and have adapted to global challenges, introducing commercial and marketable prospects for phage application. Phage Futures Europe explores the commercial applications of phages in poultry, aquaculture, biocontrol and skin microbiome, providing insights into the global design of phage products and acquiring pharmaceutical partnerships.
Visit Site
 

Christopher Mason

Weill Cornell Medicine

Christopher Mason

Weill Cornell Medicine

Christopher Mason

Weill Cornell Medicine
 
Phage Futures 2021
24-26 Feb 2021
Virtual Congress
Join us at the International Phage Futures Congress in 2021, as we create a virtual stage upon which to initiate all-important discussions & forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond.Discover how you can be at the forefront of the developing phage therapy market.Network & learn from established biotech companies, emerging start-ups, leading academics, global accelerator representatives, investment firms, international healthcare organisations & regulatory bodies. Among other topics, expect to hear & participate in:Advice on how to successfully navigate clinical trial progression to prove efficacy along with recent developments from leading biotechs in phage therapeutic trials targeting chronic & acute illnesses.Regulatory discussions between international governing bodies with region specific follow-up conversations with the experts.Insights into new fields for phage application, such as oncology, diagnostics & microbial gene therapy.Expert advice on how to find & secure financial investments.
Visit Site
Europe Pet Industry Primer
 
Skin Microbiome EU 2019
13-14 Nov 2019
London, United Kingdom
With 2.35 billion Euros being spent on cosmetic product R&D in Europe, are you ready for the next generation of skin care?Skin Microbiome continues it's reign as the 'biggest skincare trend' of the last two years, according to major market researchers and beauty bibles alike.  This year, we present the first dual-track, data-focused skin microbiome congress:Data Track: focuses on the hard data that supports and legitmises product and research claims while driving increased understanding of the skin microbiome.Commercial Track: tackles the challenges faced when building a commercially viable skin microbiome company, optimising your supply chain and executing successful communication strategies.Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Don't miss your chance to understand the next generation of skincare products!
Visit Site
 

Brian Burke

Head of Strategy
Horizon Discovery

Brian joined Horizon in 2012 during which time he has led various functions including Sales, Business Development and Product Management.  Much of his career has been focused in driving both the NGS and gene editing revolutions, most notably in the fields of diagnostics and bioprocessing.  In 2018 he was promoted to the Global Head of Strategy and now leads Horizon’s Corporate Development efforts including strategy development and M&A. 

Read full bio

Brian Burke

Head of Strategy
Horizon Discovery

Brian Burke

Head of Strategy
Horizon Discovery

Brian joined Horizon in 2012 during which time he has led various functions including Sales, Business Development and Product Management.  Much of his career has been focused in driving both the NGS and gene editing revolutions, most notably in the fields of diagnostics and bioprocessing.  In 2018 he was promoted to the Global Head of Strategy and now leads Horizon’s Corporate Development efforts including strategy development and M&A. 

 

Bruno Cluzel

Executive Director, International Operations, Diagnostics Customer Care
Zoetis

Bruno Cluzel is Executive Director, International Operations, Diagnostics Customer Care for Zoetis. In this role, he is responsible to define guidelines for customer and technical support services delivered in the markets; deliver elevated technical support and instrument repair; provide guidance to the Diagnostic Application Specialists in-market technical support; and develop and help deliver training curriculum, materials and sessions.

Read full bio

Bruno Cluzel

Executive Director, International Operations, Diagnostics Customer Care
Zoetis

Bruno Cluzel

Executive Director, International Operations, Diagnostics Customer Care
Zoetis

Bruno Cluzel is Executive Director, International Operations, Diagnostics Customer Care for Zoetis. In this role, he is responsible to define guidelines for customer and technical support services delivered in the markets; deliver elevated technical support and instrument repair; provide guidance to the Diagnostic Application Specialists in-market technical support; and develop and help deliver training curriculum, materials and sessions.

Bruno has extensive experience working within the animal health care sector. Through his career, Bruno has held various roles working across a number of different functions and regions.  

With a passion for animal health, Bruno holds a diploma of Veterinary Medicine and started his career as a Practitioner specialized in Production Animal with a focus on Avian Medicine. After 15 years in this role, he joined Merial where he had different roles across Europe Africa and Middle East: technical, marketing and business lead. He joined Pfizer Animal Health in 2011 to help entering the Diagnostics. In his current role, he is building Customer Care capabilities as Zoetis expands around the Globe.